title: Influence of eye size and beam entry angle on dose to non-targeted tissues of the eye during stereotactic x-ray radiosurgery of AMD.
abstract: Age-related macular degeneration is a leading cause of vision loss for the elderly population of industrialized nations. The IRay® Radiotherapy System, developed by Oraya® Therapeutics, Inc., is a stereotactic low-voltage irradiation system designed to treat the wet form of the disease. The IRay System uses three robotically positioned 100 kVp collimated photon beams to deliver an absorbed dose of up to 24 Gy to the macula. The present study uses the Monte Carlo radiation transport code MCNPX to assess absorbed dose to six non-targeted tissues within the eye-total lens, radiosensitive tissues of the lens, optic nerve, distal tip of the central retinal artery, non-targeted portion of the retina, and the ciliary body--all as a function of eye size and beam entry angle. The ocular axial length was ranged from 20 to 28 mm in 2 mm increments, with the polar entry angle of the delivery system varied from 18° to 34° in 2° increments. The resulting data showed insignificant variations in dose for all eye sizes. Slight variations in the dose to the optic nerve and the distal tip of the central retinal artery were noted as the polar beam angle changed. An increase in non-targeted retinal dose was noted as the entry angle increased, while the dose to the lens, sensitive volume of the lens, and ciliary body decreased as the treatment polar angle increased. Polar angles of 26° or greater resulted in no portion of the sensitive volume of the lens receiving an absorbed dose of 0.5 Gy or greater. All doses to non-targeted structures reported in this study were less than accepted thresholds for post-procedure complications.
authors.affiliation: J Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL 32611 USA.
authors.forename: Justin L
authors.initials: JL
authors.lastname: Cantley
authors.forename: Justin
authors.initials: J
authors.lastname: Hanlon
authors.forename: Erik
authors.initials: E
authors.lastname: Chell
authors.forename: Choonsik
authors.initials: C
authors.lastname: Lee
authors.forename: W Clay
authors.initials: WC
authors.lastname: Smith
authors.forename: Wesley E
authors.initials: WE
authors.lastname: Bolch
mesh_terms: D005123:Eye / Q000473:pathology* / Q000528:radiation effects*; D006801:Humans; D008268:Macular Degeneration / Q000473:pathology / Q000601:surgery*; D009010:Monte Carlo Method; D009929:Organ Size; D058958:Organs at Risk / Q000528:radiation effects*; D011829:Radiation Dosage; D016634:Radiosurgery / Q000009:adverse effects* / Q000379:methods*; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted
references.citation: Ophthalmic Surg Lasers Imaging. 2011 Nov-Dec;42(6):460-7
references.pmid: 21830745
references.citation: Invest Ophthalmol Vis Sci. 2011 Apr 08;52(5):2334-42
references.pmid: 21087954
references.citation: Ophthalmology. 1997 Oct;104(10):1634-43
references.pmid: 9331204
references.citation: Arch Ophthalmol. 2004 Apr;122(4):477-85
references.pmid: 15078664
references.citation: Med Phys. 2009 Aug;36(8):3671-81
references.pmid: 19746800
references.citation: Ophthalmology. 2013 Sep;120(9):1893-900
references.pmid: 23490327
references.citation: Ophthalmic Surg Lasers Imaging. 2005 Jul-Aug;36(4):331-5
references.pmid: 16156152
references.citation: Cochrane Database Syst Rev. 2010 May 12;(5):CD004004
references.pmid: 20464726
references.citation: Br J Ophthalmol. 2005 Jun;89(6):730-8
references.pmid: 15923510
references.citation: N Engl J Med. 2006 Oct 5;355(14):1419-31
references.pmid: 17021318
references.citation: Br J Ophthalmol. 2003 Dec;87(12):1497-503
references.pmid: 14660461
references.citation: Ophthalmology. 2005 Apr;112(4):567-73
references.pmid: 15808245
references.citation: Br J Radiol. 2000 Mar;73(867):305-13
references.pmid: 10817048
references.citation: Phys Med Biol. 2009 Jul 7;54(13):4069-87
references.pmid: 19502705
references.citation: Ophthalmology. 2006 Nov;113(11):2012-9
references.pmid: 16935343
references.citation: Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):583-97
references.pmid: 22975610
references.citation: Ann ICRP. 2012 Feb;41(1-2):1-322
references.pmid: 22925378
references.citation: Eur J Ophthalmol. 2001 Jul-Sep;11(3):269-76
references.pmid: 11681507
references.citation: Phys Med Biol. 2010 Dec 7;55(23):7037-54
references.pmid: 21076198
references.citation: Am J Ophthalmol. 1999 Feb;127(2):170-7
references.pmid: 10030559
references.citation: Graefes Arch Clin Exp Ophthalmol. 1998 Jan;236(1):24-30
references.pmid: 9457513
references.citation: Med Phys. 2008 Nov;35(11):5151-60
references.pmid: 19070249
references.citation: Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004004
references.pmid: 15495075
references.citation: Retina. 2012 Jan;32(1):10-8
references.pmid: 21817963
references.citation: N Engl J Med. 2006 Oct 5;355(14):1432-44
references.pmid: 17021319
references.citation: Ophthalmology. 1996 Jun;103(6):878-89
references.pmid: 8643242
references.citation: Med Phys. 2010 Feb;37(2):600-6
references.pmid: 20229868
references.citation: Retina. 2009 Feb;29(2):157-69
references.pmid: 19202425
references.citation: Br J Ophthalmol. 2009 Mar;93(3):305-9
references.pmid: 19019935